News25/Ratings0
Latest news
25 items- SECSEC Form 8-K filed8-K - Enveric Biosciences, Inc. (0000890821) (Filer)
- SECSEC Form 424B5 filed424B5 - Enveric Biosciences, Inc. (0000890821) (Filer)
- SECSEC Form 8-K/A filed8-K/A - Enveric Biosciences, Inc. (0000890821) (Filer)
- SECSEC Form SC 13G filedSC 13G - Enveric Biosciences, Inc. (0000890821) (Subject)
- SECSEC Form SC 13G filedSC 13G - Enveric Biosciences, Inc. (0000890821) (Subject)
- SECSEC Form 8-K filed8-K - Enveric Biosciences, Inc. (0000890821) (Filer)
- SECSEC Form 8-K/A filed8-K/A - Enveric Biosciences, Inc. (0000890821) (Filer)
- SECSEC Form 3: Llc Invest Top claimed ownership of 2,299,001 units of Common Stock3 - Enveric Biosciences, Inc. (0000890821) (Issuer)
- SECSEC Form 3 filed by Solomon Mayer3 - Enveric Biosciences, Inc. (0000890821) (Issuer)
- SECSEC Form 3 filed by A. George Kegler3 - Enveric Biosciences, Inc. (0000890821) (Issuer)
- SECSEC Form 3 filed by G. Robert Wilkins3 - Enveric Biosciences, Inc. (0000890821) (Issuer)
- SECSEC Form 3 filed by John Buiten Van3 - Enveric Biosciences, Inc. (0000890821) (Issuer)
- SECSEC Form 3 filed by Marcus Schabacker3 - Enveric Biosciences, Inc. (0000890821) (Issuer)
- SECSEC Form 3 filed by Ian David Johnson3 - Enveric Biosciences, Inc. (0000890821) (Issuer)
- SECSEC Form 3 filed by Avani Kanubaddi3 - Enveric Biosciences, Inc. (0000890821) (Issuer)
- SECSEC Form 8-K filed8-K - Enveric Biosciences, Inc. (0000890821) (Filer)
- SECSEC Form 8-K filed8-K - Enveric Biosciences, Inc. (0000890821) (Filer)
- PRAmeri Holdings Completes Spin-Off and Tender Offer, Changes Name to Enveric Biosciences and Begins Trading on the Nasdaq Under the Symbol "ENVB"NAPLES, Fla., Dec. 31, 2020 /PRNewswire/ -- Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), formerly AMERI Holdings, Inc. (NASDAQ: AMRH), a patient-centric biotechnology company endeavoring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments with novel cannabinoid medicines, announced the completion of the previously announced spin-off of the IT services business of the Company and the tender offer, whereby the Company purchased all of the outstanding common shares of Jay Pharma Inc. ("Jay Pharma") in exchange for shares of Company common stock, or if applicable, shares of Company preferred stock., and Jay Pharma became
- SECSEC Form 2 filed25-NSE - AMERI Holdings, Inc. (0000890821) (Subject)
- PRAMERI Holdings Announces 1-for-4 Reverse Stock SplitATLANTA, Dec. 30, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) ("Ameri", the "Company"), announced a 1-for-4 reverse split of its common stock, effective as of 4:02 pm Eastern Time, December 30, 2020 (the "Reverse Stock Split"). As previously announced, at the special meeting of stockholders held on December 29, 2020, Ameri's stockholders approved all proposals to complete the proposed tender offer (the "Offer"), whereby Ameri will purchase all of the outstanding common shares of Jay Pharma Inc. ("Jay Pharma") in exchange for shares of Ameri common stock, or if applicable, shares of Ameri preferred stock, at the exchange ratio set forth in the Tender Offer Support Agreement a
- PRAMERI Holdings' Stockholders Approve All Proposals To Complete Tender Offer For Jay Pharma SharesATLANTA, Dec. 29, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) ("Ameri", the "Company"), announced the voting results of the Special Meeting of stockholders that was held today. Based on the report from the Inspector of Elections, Ameri obtained sufficient votes for each proposal required to complete the previously announced proposed tender offer (the "Offer"), whereby Ameri will purchase all of the outstanding common shares of Jay Pharma Inc. ("Jay Pharma") in exchange for shares of Ameri common stock, or if applicable, shares of Ameri preferred stock, at the exchange ratio set forth in the Tender Offer Support Agreement and Termination of Amalgamation Agreement dated August
- SECSEC Form 8 filed8-K - AMERI Holdings, Inc. (0000890821) (Filer)
- SECSEC Form S filedS-4MEF - AMERI Holdings, Inc. (0000890821) (Filer)
- SECSEC Form 8 filed8-K - AMERI Holdings, Inc. (0000890821) (Filer)
- SECSEC Form 4 filed425 - AMERI Holdings, Inc. (0000890821) (Subject)
AMRH FAQ
5 questionsWhere does AMRH stock trade?
Ameri Holdings, Inc. (AMRH) is listed on NASDAQ.What sector and industry is AMRH in?
Ameri Holdings, Inc. operates in the Technology sector, Semiconductors industry.When did Ameri Holdings, Inc. go public?
Ameri Holdings, Inc. (AMRH) completed its IPO in n/a.What companies are similar to AMRH?
Notable peers in the same industry include NVDA (NVIDIA Corporation), TSM (Taiwan Semiconductor Manufacturing Company Ltd.), AVGO (Broadcom Inc.), MU (Micron Technology Inc.), AMD (Advanced Micro Devices Inc.). Compare AMRH side-by-side with any of them on Quantisnow.How can I track AMRH on Quantisnow?
Quantisnow aggregates Ameri Holdings, Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow AMRH to receive live email and push alerts on every new disclosure.